文献速递重症综合管理与镇静镇痛消化、代谢与肾脏急症

营养不良与高蛋白治疗对重症患者结局的关联:EFFORT Protein 随机试验的事后分析

The Association Between Malnutrition and High Protein Treatment on Outcomes in Critically Ill Patients: A Post Hoc Analysis of the EFFORT Protein Randomized Trial.
PubMed 文献 · Chest · 2024-02-12
一句话结论重症患者中营养不良与出院存活时间延长独立相关(aHR 0.81),但高蛋白治疗未改变该关联,挑战现有国际营养指南基于专家意见的高蛋白推荐。

该研究为 EFFORT Protein 随机对照试验的事后分析,纳入 16 个国家 1,301 例重症患者,比较高蛋白治疗(平均 1.6 g/kg/天)与常规蛋白治疗(平均 0.9 g/kg/天)。营养不良患病率为 43.8%,营养不良组与非营养不良组第 60 天存活出院累积发生率分别为 41.2% 与 52.9%。营养不良独立关联出院存活时间延长(aHR 0.81,95%CI 0.67-0.98),但高蛋白治疗在营养不良与非营养不良患者中均与出院存活时间无关联(aHR 分别为 0.84 [95%CI 0.63-1.11] 与 0.97 [95%CI 0.77-1.21]),且无效应修饰(aHR 比值 0.84,95%CI 0.58-1.20)。作者认为这些发现挑战了当前国际重症营养指南。

要点

  • 营养不良患病率 43.8%,营养不良组第 60 天存活出院累积发生率 41.2%,非营养不良组 52.9%。
  • 营养不良独立关联出院存活时间延长(aHR 0.81,95%CI 0.67-0.98)。
  • 高蛋白治疗在营养不良患者中与出院存活时间无关联(aHR 0.84,95%CI 0.63-1.11)。
  • 高蛋白治疗在非营养不良患者中与出院存活时间无关联(aHR 0.97,95%CI 0.77-1.21)。
  • 无效应修饰(aHR 比值 0.84,95%CI 0.58-1.20),作者认为挑战当前国际重症营养指南。

适用人群与场景

  • 16 个国家、1,301 例重症患者,纳入 EFFORT Protein 随机对照试验的事后分析。

诊断标准与关键阈值

  • 营养不良采用全球营养不良领导倡议(Global Leadership Initiative on Malnutrition)诊断,参数包括体重下降、肌肉消耗和 BMI。

处置流程与药物剂量

  • 高蛋白治疗组平均蛋白供给 1.6 g/kg/天,常规治疗组平均 0.9 g/kg/天。

研究设计与关键结果

  • 多中心随机对照试验事后分析,16 个国家,1,301 例重症患者,比较高蛋白治疗(平均 1.6 g/kg/天)与常规蛋白治疗(平均 0.9 g/kg/天),主要终点为出院存活时间(TTDA)。
  • 营养不良患病率 43.8%,营养不良组与非营养不良组第 60 天存活出院累积发生率分别为 41.2% 与 52.9%。
  • 营养不良独立关联出院存活时间延长(校正风险比 0.81,95%CI 0.67-0.98)。
  • 高蛋白治疗在营养不良患者中与出院存活时间无关联(校正风险比 0.84,95%CI 0.63-1.11),在非营养不良患者中亦无关联(校正风险比 0.97,95%CI 0.77-1.21)。
  • 无效应修饰(校正风险比比值 0.84,95%CI 0.58-1.20)。

证据类型、等级与局限

  • 证据类型:随机对照试验的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,营养不良与出院存活时间延长相关,但高蛋白治疗未改变该关联,这些发现挑战当前国际重症营养指南基于专家意见的高蛋白推荐。

指南或共识出处

  • 国际重症营养指南推荐对诊断为营养不良的重症患者给予高蛋白治疗以改善临床结局,但该推荐基于专家意见(原文未注明具体指南名称)。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Preexisting malnutrition in critically ill patients is associated with adverse clinical outcomes. Malnutrition can be diagnosed with the Global Leadership Initiative on Malnutrition using parameters such as weight loss, muscle wasting, and BMI. International critical care nutrition guidelines recommend high protein treatment to improve clinical outcomes in critically ill patients diagnosed with preexisting malnutrition. However, this recommendation is based on expert opinion.

RESEARCH QUESTION: In critically ill patients, what is the association between preexisting malnutrition and time to discharge alive (TTDA), and does high protein treatment modify this association?

STUDY DESIGN AND METHODS: This multicenter randomized controlled trial involving 16 countries was designed to investigate the effects of high vs usual protein treatment in 1,301 critically ill patients. The primary outcome was TTDA. Multivariable regression was used to identify if preexisting malnutrition was associated with TTDA and if protein delivery modified their association.

RESULTS: The prevalence of preexisting malnutrition was 43.8%, and the cumulative incidence of live hospital discharge by day 60 was 41.2% vs 52.9% in the groups with and without preexisting malnutrition, respectively. The average protein delivery in the high vs usual treatment groups was 1.6 g/kg per day vs 0.9 g/kg per day. Preexisting malnutrition was independently associated with slower TTDA (adjusted hazard ratio, 0.81; 95% CI, 0.67-0.98). However, high protein treatment in patients with and without preexisting malnutrition was not associated with TTDA (adjusted hazard ratios of 0.84 [95% CI, 0.63-1.11] and 0.97 [95% CI, 0.77-1.21]). Furthermore, no effect modification was observed (ratio of adjusted hazard ratio, 0.84; 95% CI, 0.58-1.20).

INTERPRETATION: Malnutrition was associated with slower TTDA, but high protein treatment did not modify the association. These findings challenge current international critical care nutrition guidelines.

CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT03160547; URL: www.

CLINICALTRIALS: gov.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Lew CCH, Lee ZY, Day AG, et al. The Association Between Malnutrition and High Protein Treatment on Outcomes in Critically Ill Patients: A Post Hoc Analysis of the EFFORT Protein Randomized Trial. Chest. 2024. PMID: 38354904. doi:10.1016/j.chest.2024.02.008

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。